NCT06619951View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Locally Advanced or Metastatic Solid Tumor
Interventions
DRUG

VC004 and Itraconazole

A single dose of VC004 was administered in the period 1. and a single dose of VC004 and Itraconazole coadministration in the period 2.

DRUG

VC004 and rifampicin

A single dose of VC004 was administered in the period 1. and a single dose of VC004 and rifampicin coadministration in the period 2.

Trial Locations (1)

Unknown

Zhongda Hospital,Affiliated to Southeast University, Nanjing

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT06619951 - A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter